Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: Shanghai Miracogen Inc.
Condition: Locally Advanced Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer
NCT05141747
A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.